US 10905692
Combination therapy for treating malignancies
granted A61KA61K2300/00A61K31/136
Quick answer
US patent 10905692 (Combination therapy for treating malignancies) held by Agios Pharmaceuticals, Inc. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2300/00, A61K31/136, A61K31/53, A61K31/704